Word

GENEX G

Status

Pending

Status Code

641

Status Date

Monday, April 22, 2024

Serial Number

79373465

Mark Type

4

Filing Date

Friday, January 27, 2023

Trademark Owner History

Biocomposites Limited

Classifications

5 Medical preparations for the treatment, reconstruction, augmentation and repair of human tissue, none being bone cement or acrylic resin for surgical and orthopaedic purposes; bone paste medical use in bone and joint surgery; bone paste incorporating pharmaceutical agents, for surgical and medical purposes; syringes sold filled with bone paste for surgical and medical purposes

10 Medical and surgical devices, apparatus and instruments all for use in bone and joint surgery, regeneration, reconstruction and augmentation; bone implants comprised of artificial materials, namely, bone repair compound for use in bone and joint surgery, bone regeneration, bone reconstruction and bone augmentation; bone implants composed of artificial materials; synthetic bone void fillers; surgical and medical implants made of artificial materials; surgical and medical implants comprised of implantable artificial materials for surgical repair, regeneration, reconstruction and augmentation of human tissue; syringes for medical purposes; medical applicators, namely, spatulas for medical use

Trademark Events

Jul 6, 2023

Sn Assigned For Sect 66a Appl From Ib

Jul 24, 2023

Limitation From Original Application Entered

Jul 25, 2023

New Application Office Supplied Data Entered

Jul 29, 2023

Application Filing Receipt Mailed

Nov 3, 2023

Non-Final Action (Ib Refusal) Prepared For Review

Oct 26, 2023

Assigned To Examiner

Nov 2, 2023

Non-Final Action Written

Mar 23, 2024

Correspondence Received In Law Office

Nov 4, 2023

Refusal Processed By Mpu

Nov 4, 2023

Non-Final Action Mailed - Refusal Sent To Ib

Nov 28, 2023

Refusal Processed By Ib

Mar 23, 2024

Teas/Email Correspondence Entered

Mar 23, 2024

Teas Response To Office Action Received

Apr 22, 2024

Notification Of Non-Final Action E-Mailed

Apr 22, 2024

Non-Final Action Written

Apr 22, 2024

Non-Final Action E-Mailed